ImmuPharma says not looking to raise funds
AIM-listed specialist drug discovery and development company ImmuPharma insisted on Wednesday that it is not looking to raise funds.
FTSE AIM All-Share
755.28
17:14 26/04/24
n/a
n/a
Immupharma
2.14p
16:49 26/04/24
0.00%
0.00p
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78
In a brief statement, the company noted the volatility in its share price following the recently-announced licensing and development agreement with US speciality pharmaceutical group Avion - which will see Avion will fund an international phase III trial for its lead programme, Lupuzor - and speculation about a possible fundraising.
"The board can confirm that the company is adequately funded and has no intention of raising funds," it said.
At 1510 GMT, the shares were up 1.5% at 18.02p.